Patents by Inventor Oliver Civelli

Oliver Civelli has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Melanin-concentrating hormone receptor antagonists and methods of use
    Patent number: 8372848
    Abstract: This invention relates generally to N-benzylamino cyclic thioureas, pharmaceutical compositions containing them, and their use as antagonists of melanin-concentrating hormone receptor (MCH receptor).
    Type: Grant
    Filed: March 23, 2005
    Date of Patent: February 12, 2013
    Assignees: Mixture Sciences, Inc., The Regents of the University of California
    Inventors: Richard A. Houghten, Colette Dooley, Adel Nefzi, Zhiwei Wang, Oliver Civelli, Hiroshi Nagasaki
  • Melanin-Concentrating Hormone Receptor Antagonists and Methods of Use
    Publication number: 20080255218
    Abstract: This invention relates generally to N-benzylamino cyclic thioureas, pharmaceutical compositions containing them, and their use as antagonists of melanin-concentrating hormone receptor (MCH receptor).
    Type: Application
    Filed: March 23, 2005
    Publication date: October 16, 2008
    Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Richard A. Houghten, Colette Dooley, Adel Nefzi, Zhiwei Wang, Oliver Civelli, Hiroshi Nagasaki
  • Dopamine receptors and genes
    Patent number: 7022816
    Abstract: A mammalian D2 dopamine receptor gene has been cloned. Thus, DNA sequences encoding all or a part of the dopamine receptor are provided, as well as the corresponding polypeptide sequences and methods for producing the same both synthetically and via expression of a corresponding sequence from a host transformed with a suitable vector carrying the corresponding DNA sequence. The various structural information provided by this invention enables the preparation of labeled or unlabeled immunospecific species, particularly antibodies, as well as nucleic acid probes labeled in conventional fashion. Pharmaceutical compositions and methods of using various products of this invention are also provided.
    Type: Grant
    Filed: August 21, 2001
    Date of Patent: April 4, 2006
    Assignee: Oregon Health and Science University
    Inventors: Oliver Civelli, James R. Bunzow, David K. Grandy, Curtis A. Machida